Published Sep 16, 2026, 4:51 PM ET · Updated 2 months ago · 1 source

Halozyme Therapeutics plans a $1.05B convertible notes sale

Seeking Alpha
Seeking Alpha
·
Original Report

Halozyme Therapeutics plans a $1.05B convertible notes sale